Look for:

Our offer for

INCYTE CORP


ISIN:
US45337C1027
WKN:
45337C102

2021/11/26 19:00:00
Price
68.38 USD
Difference 2.46% (1.64)

General attributes

ISINUS45337C1027
SymbolINCY
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)13,346 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)67.17 USD (100)
Ask (Ask size)68.54 USD (200)
Open68.77 USD
High70.58 USD
Low67.89 USD
Close (prev. day)66.74 USD
VWAP68.800091 USD
Volume (pcs)3,169,390
Trading volume217,940,744.89
Number of trades28,943
Last size237,073

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: INCYTE CORPPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2021/11/26 19:00:00
Price
68.38 USD
Difference 2.46% (1.64)

General attributes

ISINUS45337C1027
SymbolINCY
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)13,346 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)67.17 USD (100)
Ask (Ask size)68.54 USD (200)
Open68.77 USD
High70.58 USD
Low67.89 USD
Close (prev. day)66.74 USD
VWAP68.800091 USD
Volume (pcs)3,169,390
Trading volume217,940,744.89
Number of trades28,943
Last size237,073

Performance and Risk

6m1Y3Y
Perf (%)-17.77%-15.75%+1.48%
Perf (abs.)-14.78-12.78+1.00
Beta0.310.780.70
Volatility28.8331.0235.84
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)65.36 USD (2,453,895)
Ø price 30 days | Ø volume 30 days (pcs.)65.86 USD (1,925,527)
Ø price 100 days | Ø volume 100 days (pcs.)71.63 USD (1,542,954)
Ø price 250 days | Ø volume 250 days (pcs.)79.33 USD (1,346,971)
YTD High | date101.47 USD (2021/01/25)
YTD Low | date61.91 USD (2021/11/02)
52 Weeks High | date101.47 USD (2021/01/25)
52 Weeks Low | date61.91 USD (2021/11/02)

All listings for INCYTE CORP

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2021/11/2622:2659.36 EUR0.0615
Stuttgart2021/11/2621:5760.22 EUR0.0023
Nasdaq2021/11/2619:0068.38 USD217.9428,943
Munich2021/11/2608:0459.10 EUR0.002
London Stock Exchange2021/11/2615:3467.95 USD0.344
Frankfurt2021/11/2617:0261.00 EUR0.012
Duesseldorf2021/11/2619:3060.82 EUR0.0014
Berlin2021/11/2618:4261.46 EUR0.0016

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=130964&ID_TYPE_IMAGE_LOGO=2

Contact Details

INCYTE CORP.
- -
1801 Augustine Cut-Off - 19803 Wilmington
Telefon: 1-302-498-6700
Fax: -
E-mail: -

PDF Downloads

Company report: INCYTE CORPPDF Download

Company Profile

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). The company was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.

Members of Management Board

Edmund HarriganMember of Board of Directors
Jacqualyn FouseMember of Board of Directors
Katherine HighMember of Board of Directors
Otis BrawleyMember of Board of Directors
Wendy DixonMember of Board of Directors
Jean-Jacques BienaiméMember of Board of Directors
Julian BakerMember of Board of Directors
Paul ClancyMember of Board of Directors
Hervé HoppenotChairman of Managing Board
Dashyant DhanakMember of Executive Committee
Lothar H. FinkeMember of Executive Committee
Barry P. FlannellyMember of Executive Committee
Christiana StamoulisMember of Executive Committee
Jonathan E. DickinsonMember of Executive Committee
Maria E. PasqualeMember of Executive Committee
Michael MorrisseyMember of Executive Committee
Paula J. SwainMember of Executive Committee
Steven H. Stein, M.D.Member of Executive Committee
Vijay Iyengar, M.D.Member of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer